prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Total organ resection - left breast with axillary tissues. Material collected on: : Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell. nuclei. HER2 protein stained with HercepTest™ by DAKO. Score = 2+, FISH verification recommended. Macroscopic description: Left breast sized 22 x 15 x 5 cm removed along with axillary tissues sized 13 x 7.5 x 1.5 cm and a skin flap of 19 x 11 cm. Retracted nipple. Tumour sized 2.5 x 2 x 2.8 cm found on the boundary of lower quadrants, located 3.5 cm from the lower. boundary, 0.4 cm from the base and 3 cm from the skin. Microscopic description: Carcinoma ductale invasivum - NHG2 (2+2+3/21 mitoses/10 HPF - visual area 0.57mm). Glandular tissue showing. lesions of the type mastopathia fibrosa et cystica, hyperplasia ductalis simplex (UDH 1. AXILLARY LYMPH NODES: Metastases carcinomatosae in lymphonodis (No III/XXIII). Infiltratio capsulae lymphonodorum. Histopathological diagnosis: Carcinoma ductale invasivum mammae sinistrae. Invasive ductal carcinoma of the left breast. Metastases carcinomatosae in lymphonodosi axillae (No III/XXIII) (NHG2, pT2, pNIa). Cancer metasta ° of axillary lymph nodes (No III/XXIII) (NHG2, pT2, pNIa). S. Examination: Histopathological examination. page 2 / 2. Gender: F. Results of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND.

expanded version (tokens=923) : 
 From the breast pathology report, the following information can be extracted:

1. Histological classification: Carcinoma ductale invasivum (invasive ductal carcinoma) of the left breast.
2. Subtype: LumA.
3. Description of necrosis: No mention of necrosis.
4. Tumor infiltrating lymphocytes: No mention of tumor infiltrating lymphocytes.
5. Histological grade: NHG2 (2+2+3/21 mitoses/10 HPF - visual area 0.57mm).
6. Nuclear grade: NHG2.
7. Lymphovascular invasion: Not mentioned.
8. Calcification: Not mentioned.
9. Receptor status: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 gene amplification not found.
10. IHC and ancillary testing results: HER2 protein stained with HercepTest™ by DAKO. Score = 2+, FISH verification recommended. Result of HER2/neu gene amplification with the FISH method by PathVysion HER2 DNA Probe Kit: HER-2 gene amplification not found.

It is important to note that there is a metastasis of carcinomatosae in the lymphonodosi axillae (No III/XXIII), which means that the cancer has spread to the axillary lymph nodes

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1058) : 
 The report indicates the presence of LumA subtype invasive ductal carcinoma in the left breast along with metastases in the axillary lymph nodes. The tumor exhibited moderate differentiation and hormone receptor status positive for both estrogen and progesterone. HER2 overexpression was observed on immunohistochemical staining, but FISH verification showed HER-2 gene amplification to be negative. No significant necrosis or calcifications were detected in the tumor.

